This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsuiki, H. Articles by Wong, A. J. Search for Related Content PubMed PubMed Citation Articles by Tsuiki, H. Articles by Wong, A. J.

Constitutively Active Forms of c-Jun NH₂-terminal Kinase Are Expressed in Primary Glial Tumors¹

Departments of Microbiology and Immunology, Kimmel Cancer Institute [H. T., M. T., I. O., D. R. E., M. H-M., I. S. L., C. J. J., K. T. V., A. J. W.], and Pathology, Anatomy, and Cell Biology [L. C. K.], Thomas Jefferson University, Philadelphia, Pennsylvania 19107

The c-Jun NH₂-terminal kinases (JNKs) have a role both in promoting apoptosis and tumorigenesis.The JNKs are encoded by three separate genes (JNK1, 2, and 3), whichare spliced alternatively to create 10 JNK isoforms that are either M_r 55,000 or 46,000 in size. However, the functional significance and distinct role for each splice variant remains unclear. We have noted previously that 86% of primary human glial tumors show activation of almost exclusively the M_r 55,000 isoforms of JNK. To further study which isoforms are involved, we constructed glutathione S-transferase fusion proteins for all 10 JNK isoforms and examined kinase activity with or without the activating upstream kinase. Surprisingly, five JNK isoforms demonstrate autophosphorylation activity, and in addition, all four JNK2 isoforms (either M_r 55,000 or 46,000) show a high basal level of substrate kinase activity in the absence of the upstream kinase, especially a M_r 55,000 JNK2 isoform. Examination revealed autophosphorylation activity at the T-P-Y motif, which is critical for JNK activation, because a mutant lacking the dual phosphorylation sites did not show autophosphorylation or basal kinase activity. Using green fluorescence protein-JNK expression vectors, transient transfection into U87MG cells demonstrates that although the JNK1 isoforms localize predominantly to the cytoplasm, the JNK2 isoforms localize to the nucleus and are phosphorylated, confirming the constitutive activation seen in vitro. We then examined which JNK isoforms are active in glial tumors by performing two-dimensional electrophoresis. This revealed that the M_r 55,000 isoforms of JNK2 are the principal active JNK isoforms present in tumors. Collectively, these results suggest that these constitutively active JNK isoforms play a significant role in glial tumors. Aside from epidermal growth factor receptor vIII, this is the only other kinase that has been shown to be basally active in glioma. The presence of constitutively active JNK isoforms may have implications for the design of inhibitors of the JNK pathway.

This article has been cited by other articles:

				R. T. Nitta, A. H. Chu, and A. J. Wong Constitutive Activity of JNK2{alpha}2 Is Dependent on a Unique Mechanism of MAPK Activation J. Biol. Chem., December 12, 2008; 283(50): 34935 - 34945. [Abstract] [Full Text] [PDF]

				T. Boutros, E. Chevet, and P. Metrakos Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer Pharmacol. Rev., September 1, 2008; 60(3): 261 - 310. [Abstract] [Full Text] [PDF]

				A. Mangiola, G. Lama, C. Giannitelli, P. De Bonis, C. Anile, L. Lauriola, G. La Torre, G. Sabatino, G. Maira, M. Jhanwar-Uniyal, et al. Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications Clin. Cancer Res., December 1, 2007; 13(23): 6970 - 6977. [Abstract] [Full Text] [PDF]

				J. Y. Zhang, A. E. Adams, T. W. Ridky, S. Tao, and P. A. Khavari Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia Cancer Res., April 15, 2007; 67(8): 3827 - 3834. [Abstract] [Full Text] [PDF]

				S. Zhong, J. Fromm, and D. L. Johnson TBP Is Differentially Regulated by c-Jun N-Terminal Kinase 1 (JNK1) and JNK2 through Elk-1, Controlling c-Jun Expression and Cell Proliferation Mol. Cell. Biol., January 1, 2007; 27(1): 54 - 64. [Abstract] [Full Text] [PDF]

				C. Nielsen, J. Thastrup, T. Bottzauw, M. Jaattela, and T. Kallunki c-Jun NH2-Terminal Kinase 2 Is Required for Ras Transformation Independently of Activator Protein 1 Cancer Res., January 1, 2007; 67(1): 178 - 185. [Abstract] [Full Text] [PDF]

				J. Cui, S.-Y. Han, C. Wang, W. Su, L. Harshyne, M. Holgado-Madruga, and A. J. Wong c-Jun NH2-Terminal Kinase 2{alpha}2 Promotes the Tumorigenicity of Human Glioblastoma Cells. Cancer Res., October 15, 2006; 66(20): 10024 - 10031. [Abstract] [Full Text] [PDF]

				T. Rosenzweig, A. Ziv-Av, C. Xiang, W. Lu, S. Cazacu, D. Taler, C. G. Miller, R. Reich, Y. Shoshan, Y. Anikster, et al. Related to Testes-Specific, Vespid, and Pathogenesis Protein-1 (RTVP-1) Is Overexpressed in Gliomas and Regulates the Growth, Survival, and Invasion of Glioma Cells. Cancer Res., April 15, 2006; 66(8): 4139 - 4148. [Abstract] [Full Text] [PDF]

				Y. M. Whang, Y. H. Kim, J. S. Kim, and Y. D. Yoo RASSF1A Suppresses the c-Jun-NH2-Kinase Pathway and Inhibits Cell Cycle Progression Cancer Res., May 1, 2005; 65(9): 3682 - 3690. [Abstract] [Full Text] [PDF]

				J. Cui, M. Holgado-Madruga, W. Su, H. Tsuiki, P. Wedegaertner, and A. J. Wong Identification of a Specific Domain Responsible for JNK2{alpha}2 Autophosphorylation J. Biol. Chem., March 18, 2005; 280(11): 9913 - 9920. [Abstract] [Full Text] [PDF]

				W. Reiley, M. Zhang, and S.-C. Sun Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD J. Biol. Chem., December 31, 2004; 279(53): 55161 - 55167. [Abstract] [Full Text] [PDF]

				T. Tonini, C. Gabellini, L. Bagella, G. D'Andrilli, V. Masciullo, G. Romano, G. Scambia, G. Zupi, and A. Giordano pRb2/p130 Decreases Sensitivity to Apoptosis Induced by Camptothecin and Doxorubicin but not by Taxol Clin. Cancer Res., December 1, 2004; 10(23): 8085 - 8093. [Abstract] [Full Text] [PDF]

				R. A. MacCorkle and T.-H. Tan Inhibition of JNK2 Disrupts Anaphase and Produces Aneuploidy in Mammalian Cells J. Biol. Chem., September 17, 2004; 279(38): 40112 - 40121. [Abstract] [Full Text] [PDF]